ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
ONCOGENE
Volume 30, Issue 6, Pages 701-713
Publisher
Springer Nature
Online
2010-10-11
DOI
10.1038/onc.2010.441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Standards for the Treatment of Relapsed Chronic Lymphocytic Leukemia: A Case-Based Study
- (2010) Arnon P. Kater et al. Clinical Lymphoma Myeloma & Leukemia
- Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells
- (2010) M. Baou et al. HAEMATOLOGICA
- A p38MAPK/HIF-1 Pathway Initiated by UVB Irradiation Is Required to Induce Noxa and Apoptosis of Human Keratinocytes
- (2010) Kris Nys et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells
- (2009) C. P. Miller et al. BLOOD
- PCI-24781 Induces Caspase and Reactive Oxygen Species-Dependent Apoptosis Through NF- B Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells
- (2009) S. Bhalla et al. CLINICAL CANCER RESEARCH
- Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction
- (2009) R Mous et al. LEUKEMIA
- R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia
- (2009) S H Tonino et al. LEUKEMIA
- Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels
- (2008) Nuria Garrido et al. BIOCHEMICAL JOURNAL
- c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches
- (2008) D. Y. H. Hallaert et al. BLOOD
- Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
- (2008) C. Pepper et al. BLOOD
- Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
- (2008) M. Vogler et al. BLOOD
- Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism
- (2008) D. Trachootham et al. BLOOD
- Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up
- (2008) T. Zenz et al. BLOOD
- Prognostic markers in chronic lymphocytic leukemia: A comprehensive review
- (2008) Femke Van Bockstaele et al. BLOOD REVIEWS
- Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells
- (2008) Amel Baya Bouzar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Bendamustine Is Effective in p53-Deficient B-Cell Neoplasms and Requires Oxidative Stress and Caspase-Independent Signaling
- (2008) G. Roue et al. CLINICAL CANCER RESEARCH
- Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy in Patients With Richter's Syndrome or Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2008) Apostolia M. Tsimberidou et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions
- (2008) Roberto R. Rosato et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started